Evidence map›Paper›PMID 38643192›Full record

ArticleCell death discovery2024

N4BP1 functions as a dimerization-dependent linear ubiquitin reader which regulates TNF signalling.

Katarzyna W Kliza, Wei Song, Irene Pinzuti, Simone Schaubeck, Simone Kunzelmann, David Kuntin, Arianna Fornili, Alessandro Pandini, Kay Hofmann, James A Garnett and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Traumatic brain injury induces cell-type-specific remodelling of the proteostasis network.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Article
  2. Article
  3. N4BP1 acts as a potent negative regulator of IL-17 signaling by blocking the translation of Act1 mRNA.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Katarzyna W Kliza *Institute of Biochemistry II, Goethe University School of Medicine, Frankfurt (Main), Germany. katarzyna.kliza@mpi-dortmund.mpg.de.ORCID http://orcid.org/0000-0002-1213-1812
Wei Song *School of Biological and Behavioural Sciences, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0002-2834-5671
Irene PinzutiSchool of Biological and Behavioural Sciences, Queen Mary University of London, London, UK.
Simone SchaubeckInstitute of Biochemistry II, Goethe University School of Medicine, Frankfurt (Main), Germany.
Simone KunzelmannStructural Biology Science Technology Platform, Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-2678-0549
David KuntinInstitute of Biochemistry II, Goethe University School of Medicine, Frankfurt (Main), Germany.
Arianna ForniliSchool of Physical and Chemical Sciences, Queen Mary University of London, London, UK.
Alessandro PandiniDepartment of Computer Science, Brunel University London, Uxbridge, UK.
Kay HofmannInstitute for Genetics, University of Cologne, Cologne, Germany.
James A GarnettCentre for Host-Microbiome Interactions, Dental Institute, King's College London, London, UK.
Benjamin StieglitzSchool of Biological and Behavioural Sciences, Queen Mary University of London, London, UK. b.stieglitz@qmul.ac.uk.ORCID http://orcid.org/0000-0003-3634-6997
Koraljka HusnjakInstitute of Biochemistry II, Goethe University School of Medicine, Frankfurt (Main), Germany. k.husnjak@biochem2.uni-frankfurt.de.
Goethe University Frankfurt · DEQueen Mary University of London · GBBrunel University of London · GBKing's College London · GBThe Francis Crick Institute · GBUniversity of Cologne · DE

Funding

Wellcome Trust FC001029
6 · The paper itself

Abstract

Signalling through TNFR1 modulates proinflammatory gene transcription and programmed cell death, and its impairment causes autoimmune diseases and cancer. NEDD4-binding protein 1 (N4BP1) is a critical suppressor of proinflammatory cytokine production that acts as a regulator of innate immune signalling and inflammation. However, our current understanding about the molecular properties that enable N4BP1 to exert its suppressive potential remain limited. Here, we show that N4BP1 is a novel linear ubiquitin reader that negatively regulates NFκB signalling by its unique dimerization-dependent ubiquitin-binding module that we named LUBIN. Dimeric N4BP1 strategically positions two non-selective ubiquitin-binding domains to ensure preferential recognition of linear ubiquitin. Under proinflammatory conditions, N4BP1 is recruited to the nascent TNFR1 signalling complex, where it regulates duration of proinflammatory signalling in LUBIN-dependent manner. N4BP1 deficiency accelerates TNFα-induced cell death by increasing complex II assembly. Under proapoptotic conditions, caspase-8 mediates proteolytic processing of N4BP1, resulting in rapid degradation of N4BP1 by the 26 S proteasome, and acceleration of apoptosis. In summary, our findings demonstrate that N4BP1 dimerization creates a novel type of ubiquitin reader that selectively recognises linear ubiquitin which enables the timely and coordinated regulation of TNFR1-mediated inflammation and cell death.

Identifiers

PMID38643192
PMCPMC11032371
OpenAlexW4394987922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.